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CA

:   cancer antigen

CEA

:   carcinoembryonic antigen

CI

:   confidence interval

Cp

:   crossing point

IPMN

:   intraductal papillary mucinous neoplasm

NPV

:   negative predictive value

PDAC

:   pancreatic ductal adenocarcinoma

PPV

:   positive predictive value

RTD‐PCR

:   real‐time detection PCR

1. INTRODUCTION {#cas13971-sec-0001}
===============

Pancreatic ductal adenocarcinoma is among the most difficult malignancies to diagnose and treat, resulting in poor prognosis.[1](#cas13971-bib-0001){ref-type="ref"}, [2](#cas13971-bib-0002){ref-type="ref"} Approximately 10% of PDAC patients are diagnosed in an early phase (ie, stage I and II), when radical treatment involving surgical removal of the PDAC lesions is available.[3](#cas13971-bib-0003){ref-type="ref"}, [4](#cas13971-bib-0004){ref-type="ref"} Chemotherapy has only limited efficacy in terms of prolonging the survival of PDAC patients.[5](#cas13971-bib-0005){ref-type="ref"} The overall survival after diagnosis of PDAC is less than 5 years, which is the poorest among all digestive system malignancies. Therefore, novel diagnostic tools capable of detecting PDAC in the early stages, as well as sufficiently effective treatment options to substantially improve the prognosis of PDAC, are required.

Previously, we reported that the gene expression profile of peripheral blood showed characteristic alterations in the digestive system of cancer patients.[6](#cas13971-bib-0006){ref-type="ref"} The local cancer tissues of PDAC were substantially infiltrated with inflammatory cells, including immune‐suppressing cells as well as lymphocytes expressing the immune checkpoint molecule, programmed cell death 1 (PD‐1). In addition, certain genes expressed in whole peripheral blood, as well as CD4^+^ cells and CD14^+^ cells, were found to be important in the inflammation seen in PDAC.[7](#cas13971-bib-0007){ref-type="ref"} Therefore, peripheral blood cells reflect the host inflammatory condition in association with local cancer tissues in PDAC.

We developed a blood mRNA PDAC screening system based on determining changes in the mRNA expression levels of 56 genes in whole blood by RTD‐PCR. We undertook a multi‐institutional clinical study to test the performance of this system. The system performance was assessed in 53 PDAC patients, 102 noncancer subjects, 22 chronic pancreatitis patients, and 23 IPMN patients. The system showed sensitivity of 73.6% (95% CI, 59.7%‐84.7%). The specificity for noncancer volunteers, chronic pancreatitis patients, and IPMN patients was 64.7% (54.6%‐73.9%), 63.6% (40.7%‐82.8%), and 47.8% (26.8%‐69.4%), respectively. Thus, the screening system, based on examination of changes in gene expression in blood, could be useful.

2. MATERIALS AND METHODS {#cas13971-sec-0002}
========================

2.1. Complementary DNA microarray analysis to determine gene expression in whole blood {#cas13971-sec-0003}
--------------------------------------------------------------------------------------

Twenty‐eight PDAC patients and 27 noncancer subjects (Table [S1](#cas13971-sup-0003){ref-type="supplementary-material"}) were enrolled for gene expression analysis of whole blood cells, to select candidate genes for establishing a blood PDAC screening system. For blood collection, we used PAXgene blood RNA tubes (PreAnalytix, Hombrechtikon, Switzerland) in which the RNA of whole blood cells was immediately stabilized after collection and mixed with reagents in the tubes. The study was approved by the Institutional Review Board of Kanazawa University (Kanazawa, Japan) and its related hospitals.

We used a cDNA microarray Whole Human Genome 4× 44K Array kit (G4112F; Agilent Technologies, Santa Clara, CA, USA) for analysis of gene expression of whole blood obtained from 17 PDAC patients and 13 noncancer subjects, as described previously.[7](#cas13971-bib-0007){ref-type="ref"} Briefly, RNA was extracted from PAXgene blood RNA tubes using a PAXgene Blood RNA System kit (PreAnalytix) in accordance with the manufacturer\'s protocol, followed by RNA quantification using a NanoDrop ND‐1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Cy‐3‐labeled cRNA was synthesized from 300 ng total RNA using a Quick Amp Labeling kit, and then hybridized to the cDNA microarray. The hybridized microarray was scanned using a cDNA Microarray Scanner (Model G2505B; Agilent Technologies), and the obtained image was processed using Feature Extraction software version 9.5.3.1 (Agilent Technologies) to obtain the value data. The data, which were normalized using GeneSpring GX software version 11.0.2 (Agilent Technologies), were used to select candidate genes for RTD‐PCR analysis. The cDNA microarray data were deposited in Gene Expression Omnibus (NBCI, Bethesda, MD, USA) with the number GSE125158.

2.2. Real‐time detection PCR {#cas13971-sec-0004}
----------------------------

Gene expression analysis by RTD‐PCR for candidate genes selected from cDNA microarray data was undertaken as described previously.[7](#cas13971-bib-0007){ref-type="ref"} Briefly, cDNA was synthesized from total RNA extracted from samples in PAXgene Blood RNA tubes using an RT^2^ HT First Strand Kit (Qiagen, Hilden, Germany). Synthesized cDNA was measured using Custom RT^2^ Profiler PCR Arrays (Qiagen) according to the manufacturer\'s instructions. Quantitative PCR was carried out using a LightCycler 480 Instrument II version 1.5.0.39 (Roche, Basel, Switzerland).

2.3. Selection of genes for blood mRNA screening system {#cas13971-sec-0005}
-------------------------------------------------------

To establish the mRNA blood screening system, we used blood RNA from 28 PDAC patients and 27 noncancer subjects. Using RTD‐PCR, we measured the mRNA expression levels of candidate genes whose expression was assessed by cDNA microarray. For the selection of genes, we used a support vector machine with the linear kernel and sequential variable erasing methods.[8](#cas13971-bib-0008){ref-type="ref"} Discrimination between PDAC and noncancer subjects was undertaken using Fisher\'s linear discriminant with a penalized matrix for gene expression correlation analysis. We applied leave‐one‐out cross‐validation, using the RTD‐PCR data of 1 case as a test dataset for both gene selection and classifier building. Discrimination ability was assessed according to the sensitivity and specificity. The number of genes used for classification was based on cross‐validated sensitivity and specificity. Finally, we developed a final classifier by applying the whole algorithm with the determined number of genes to all 55 cases to be mounted in the blood mRNA screening system.

2.4. Clinical study design to assess performance of blood mRNA screening system {#cas13971-sec-0006}
-------------------------------------------------------------------------------

The clinical study to test the system performance was designed in consultation with the Japanese Pharmaceutical and Medical Device Agency, which is a Japanese regulatory agency, working together with the Ministry of Health, Labour, and Welfare to protect public health by assuring the safety, efficacy, and quality of pharmaceuticals and medical devices, and was approved by each participating institutional ethical committee (UMIN000020758). The primary end‐points were sensitivity and specificity of the blood mRNA PDAC screening system. The secondary end‐points were the PPV and NPV for the blood mRNA PDAC screening system, and the sensitivity, specificity, PPV, and NPV for CEA and CA19‐9. The clinical study was undertaken in 50 PDAC patients and 100 noncancer subjects. We also enrolled patients with IPMN and chronic pancreatitis, whose clinical data were not available. The inclusion criteria were as follows: PDAC patients, diagnosis by imaging studies or pathologically; chronic pancreatitis and IPMN patients, diagnosis by imaging studies; and non‐cancer subjects, considered normal based on medical records for the previous year or on current medical check‐up. The subjects were aged between 40 and 90 years. All subjects provided written informed consent prior to participating in the study. Exclusion criteria are shown in Table [S2](#cas13971-sup-0004){ref-type="supplementary-material"}. The participating institutions were as follows (all based in Japan): Department of Gastroenterology, Kanazawa University Hospital; Department of Internal Medicine, Toyama Prefectural Central Hospital; Department of Gastroenterology, Toyama Municipal Hospital; Department of Gastroenterology, Tonami General Hospital; Department of Gastroenterology, Kanazawa Medical Center; Ishikawa Saiseikai Kanazawa Hospital; Department of Gastroenterology, Matto Ishikawa Central Hospital; Fukui Saiseikai Hospital; Department of Gastroenterology, Tsuruga Hospital; and Department of Internal Medicine, Keijyu General Hospital.

Blood was collected using PAXgene blood RNA tubes (PreAnalytiX) for mRNA expression measurement. Sera were also collected for CEA and CA19‐9 measurement by the standard chemiluminescent enzyme immunoassay. Results of CEA greater than 5.0 ng/mL and CA19‐9 greater than 37.0 U/mL were judged to be positive.

2.5. Statistical analysis {#cas13971-sec-0007}
-------------------------

For the clinical validation study, we used Wilcoxon\'s signed‐rank test or Fisher\'s exact test for group comparisons. In evaluating the system performance, point estimates and 95% CIs of sensitivity and specificity were calculated. Pearson\'s correlation analysis and *t* test were applied using IBM SPSS Statistics (IBM, Armonk, NY, USA).

3. RESULTS {#cas13971-sec-0008}
==========

3.1. Establishment of blood PDAC screening system {#cas13971-sec-0009}
-------------------------------------------------

We reported previously that the gene expression profile of whole blood cells from the digestive system of cancer patients was different from that of normal noncancer subjects.[6](#cas13971-bib-0006){ref-type="ref"} Based on these findings, we established a blood PDAC screening system using RTD‐PCR for genes, the expression levels of which in whole blood were altered in PDAC patients. We first extracted 2 sets of 384 genes assessing the cDNA microarray data of 17 PDAC patients and 13 noncancer subjects (GSE125158). The 384 genes in 1 set were selected by their expression, which was affected at FC \>1.5 and *P* \< 0.00013. The other set of 384 genes was selected by a powerful machine learning algorithms‐random forest method,[9](#cas13971-bib-0009){ref-type="ref"} in which 200 bootstraps were used to find the top genes that have more power to distinguish PDAC from noncancer subjects. The 179 genes that were included in both gene sets were finally selected. From the remaining genes in this analysis, we chose 134 genes, considering their biological meanings. We also selected 51 genes, whose flags for expression were positive in 12 of 17 PDAC patients and absent in 10 of 13 noncancer subjects. Thus, we finally selected 364 genes to further construct the equation for the PDAC screening system (Figure [S1](#cas13971-sup-0001){ref-type="supplementary-material"}). For 28 PDAC patients and 27 noncancer subjects, including the above subjects, we carried out RTD‐PCR of these 364 genes and 17 housekeeping genes including *GAPDH* (Table [S3](#cas13971-sup-0005){ref-type="supplementary-material"}). We used *GAPDH* as a reference as its expression was substantial and showed no difference between PDAC patients and noncancer subjects. Therefore, we have used delta Cp, which was obtained by subtraction of the *GAPDH* Cp value from that of each gene, for mRNA expression. To determine the gene number for discrimination of PDAC and noncancer subjects, we used the statistical method applied with the support vector machine and recursive feature elimination[8](#cas13971-bib-0008){ref-type="ref"} during the leave‐one‐out cross‐validation among these 55 cases (Figure [S2](#cas13971-sup-0002){ref-type="supplementary-material"}). The cross‐validated sensitivity and specificity to discriminate PDAC from noncancer subjects were sufficiently high (93% and 100%, respectively) based on 56 genes; increasing the number of genes above 56 did not increase discrimination performance. By this analysis, we found that 56 genes were sufficient for the most excellent accuracy.

Therefore, we finally selected 56 genes (Table [1](#cas13971-tbl-0001){ref-type="table"}) for expression analysis in whole blood cells in 28 PDAC and 27 noncancer subjects.

###### 

Fifty‐six genes, their annotations, and coefficient values for equation of the blood mRNA screening system

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Refseq \#      Gene symbol         Gene description                                                Coefficient value   GOTERM_Biological process (BP)                                                                                                                      GOTERM_Cellular component (CC)                        GOTERM_Molecular function (MF)
  -------------- ------------------- --------------------------------------------------------------- ------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  NM_138340      *SLC44A1*           Solute carrier family 44 member 1                               18.88705            GO:0006656\~phosphatidylcholine biosynthetic process,\                                                                                              GO:0005654\~nucleoplasm,\                             GO:0015220\~choline transmembrane transporter activity
                                                                                                                         GO:0015871\~choline transport,\                                                                                                                     GO:0005739\~mitochondrion,\                           
                                                                                                                         GO:0042426\~choline catabolic process,\                                                                                                             GO:0016020\~membrane,\                                
                                                                                                                         GO:0055085\~transmembrane transport                                                                                                                 GO:0070062\~extracellular exosome                     

  NM_005470      *ABHD3*             Abhydrolase domain containing 3                                 18.25234            GO:0006629\~lipid metabolic process,\                                                                                                               GO:0005886\~plasma membrane,\                         GO:0004623\~phospholipase A2 activity,\
                                                                                                                         GO:0046470\~phosphatidylcholine metabolic process                                                                                                   GO:0016021\~integral component of membrane            GO:0008970\~phosphatidylcholine 1‐acylhydrolase activity,\
                                                                                                                                                                                                                                                                                                                                   GO:0052739\~phosphatidylserine 1‐acylhydrolase activity,\
                                                                                                                                                                                                                                                                                                                                   GO:0052740\~1‐acyl‐2‐lysophosphatidylserine acylhydrolase activity

  NM_004457      *PTPRC*             Protein tyrosine phosphatase, receptor type C                   15.18565            GO:0001915\~negative regulation of T cell mediated cytotoxicity,\                                                                                   GO:0005886\~plasma membrane\                          GO:0005001\~transmembrane receptor protein tyrosine phosphatase activity,\
                                                                                                                         GO:0001960\~negative regulation of cytokine‐mediated signaling pathway,\                                                                            GO:0005925\~focal adhesion,\                          GO:0005515\~protein binding,\
                                                                                                                         GO:0002244\~hematopoietic progenitor cell differentiation,\                                                                                         GO:0045121\~membrane raft,\                           GO:0019901\~protein kinase binding
                                                                                                                         GO:0002378\~immunoglobulin biosynthetic process,\                                                                                                   GO:0070062\~extracellular exosome                     
                                                                                                                         GO:0030217\~T cell differentiation,\                                                                                                                                                                      
                                                                                                                         GO:0030890\~positive regulation of B cell proliferation,\                                                                                                                                                 
                                                                                                                         GO:0048539\~bone marrow development,\                                                                                                                                                                     
                                                                                                                         GO:0048864\~stem cell development,\                                                                                                                                                                       
                                                                                                                         GO:0050852\~T cell receptor signaling pathway,\                                                                                                                                                           
                                                                                                                         GO:0050857\~positive regulation of antigen receptor‐mediated signaling pathway                                                                                                                            

  NM_001628      *TLE2*              Transducin like enhancer of split 2                             14.37697            GO:0006351\~transcription, DNA‐templated,\                                                                                                          GO:0005615\~extracellular space,\                     GO:0003714\~transcription corepressor activity,\
                                                                                                                         GO:0007165\~signal transduction,\                                                                                                                   GO:0005634\~nucleus,\                                 GO:0005515\~protein binding
                                                                                                                         GO:0016055\~Wnt signaling pathway,\                                                                                                                 GO:0005925\~focal adhesion                            
                                                                                                                         GO:0045892\~negative regulation of transcription, DNA‐templated,\                                                                                                                                         
                                                                                                                         GO:1904837\~beta‐catenin‐TCF complex assembly                                                                                                                                                             

  NM_014616      *FNDC3B*            Fibronectin type III domain containing 3B                       14.19903            ---                                                                                                                                                 GO:0016021\~integral component of membrane            GO:0044822\~poly(A) RNA binding

  NM_032047      *LDHA*              Lactate dehydrogenase A                                         13.84082            GO:0001666\~response to hypoxia,\                                                                                                                   GO:0005634\~nucleus,\                                 GO:0004459\~L‐lactate dehydrogenase activity,\
                                                                                                                         GO:0005975\~carbohydrate metabolic process,\                                                                                                        GO:0005737\~cytoplasm,\                               GO:0016616\~oxidoreductase activity, acting on the CH‐OH group of donors, NAD or NADP as acceptor,\
                                                                                                                         GO:0006089\~lactate metabolic process,\                                                                                                             GO:0005913\~cell‐cell adherens junction,\             GO:0019900\~kinase binding,\
                                                                                                                         GO:0006090\~pyruvate metabolic process,\                                                                                                            GO:0016020\~membrane,\                                GO:0042802\~identical protein binding,\
                                                                                                                         GO:0006096\~glycolytic process,GO:0007584\~response to nutrient,\                                                                                   GO:0016021\~integral component of membrane,\          GO:0051287\~NAD binding,\
                                                                                                                         GO:0042542\~response to hydrogen peroxide,\                                                                                                         GO:0070062\~extracellular exosome                     GO:0098641\~cadherin binding involved in cell‐cell adhesion
                                                                                                                         GO:0043065\~positive regulation of apoptotic process,\                                                                                                                                                    
                                                                                                                         GO:0043627\~response to estrogen,\                                                                                                                                                                        
                                                                                                                         GO:0051591\~response to cAMP,\                                                                                                                                                                            
                                                                                                                         GO:0055114\~oxidation‐reduction process,\                                                                                                                                                                 
                                                                                                                         GO:0098609\~cell‐cell adhesion                                                                                                                                                                            

  NM_001186      *RPLP1*             Ribosomal protein lateral stalk subunit P1                      13.75907            GO:0000184\~nuclear‐transcribed mRNA catabolic process, nonsense‐mediated decay,\                                                                   GO:0005737\~cytoplasm,\                               GO:0003735\~structural constituent of ribosome,\
                                                                                                                         GO:0002181\~cytoplasmic translation,\                                                                                                               GO:0005840\~ribosome,\                                GO:0005515\~protein binding,\
                                                                                                                         GO:0006364\~rRNA processing,\                                                                                                                       GO:0005925\~focal adhesion,\                          GO:0030295\~protein kinase activator activity,\
                                                                                                                         GO:0045860\~positive regulation of protein kinase activity                                                                                          GO:0070062\~extracellular exosome                     GO:0070180\~large ribosomal subunit rRNA binding

  NM_001145054   *RAB10*             RAB10, member RAS oncogene family                               13.27343            GO:0006893\~Golgi to plasma membrane transport,\                                                                                                    GO:0000139\~Golgi membrane,\                          GO:0003924\~GTPase activity,\
                                                                                                                         GO:0007264\~small GTPase mediated signal transduction,\                                                                                             GO:0000145\~exocyst,\                                 GO:0005515\~protein binding,\
                                                                                                                         GO:0007409\~axonogenesis,\                                                                                                                          GO:0005622\~intracellular,\                           GO:0005525\~GTP binding,\
                                                                                                                         GO:0016192\~vesicle‐mediated transport,\                                                                                                            GO:0005768\~endosome,\                                GO:0019003\~GDP binding,\
                                                                                                                         GO:0016197\~endosomal transport,\                                                                                                                   GO:0005789\~endoplasmic reticulum membrane,\          GO:0031489\~myosin V binding,\
                                                                                                                         GO:0019882\~antigen processing and presentation,\                                                                                                   GO:0005886\~plasma membrane,\                         GO:0098641\~cadherin binding involved in cell‐cell adhesion
                                                                                                                         GO:0030859\~polarized epithelial cell differentiation,\                                                                                             GO:0005911\~cell‐cell junction,\                      
                                                                                                                         GO:0032869\~cellular response to insulin stimulus,\                                                                                                 GO:0005913\~cell‐cell adherens junction,\             
                                                                                                                         GO:0071786\~endoplasmic reticulum tubular network organization,\                                                                                    GO:0005925\~focal adhesion,\                          
                                                                                                                         GO:0072659\~protein localization to plasma membrane,\                                                                                               GO:0030670\~phagocytic vesicle membrane,\             
                                                                                                                         GO:0097051\~establishment of protein localization to endoplasmic reticulum membrane,\                                                               GO:0032593\~insulin‐responsive compartment,\          
                                                                                                                         GO:0098609\~cell‐cell adhesion                                                                                                                      GO:0055038\~recycling endosome membrane,\             
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome,\                   
                                                                                                                                                                                                                                                                             GO:0071782\~endoplasmic reticulum tubular network     

  NM_152523      *HTATIP2*           HIV‐1 Tat interactive protein 2                                 12.98543            GO:0001525\~angiogenesis,\                                                                                                                          GO:0005634\~nucleus,\                                 GO:0003713\~transcription coactivator activity,\
                                                                                                                         GO:0006357\~regulation of transcription from RNA polymerase II promoter,\                                                                           GO:0005635\~nuclear envelope,\                        GO:0005515\~protein binding,\
                                                                                                                         GO:0006915\~apoptotic process,\                                                                                                                     GO:0005654\~nucleoplasm,\                             GO:0016491\~oxidoreductase activity
                                                                                                                         GO:0016032\~viral process,\                                                                                                                         GO:0005737\~cytoplasm,\                               
                                                                                                                         GO:0030154\~cell differentiation,\                                                                                                                  GO:0016020\~membrane                                  
                                                                                                                         GO:0051170\~nuclear import,\                                                                                                                                                                              
                                                                                                                         GO:0055114\~oxidation‐reduction process                                                                                                                                                                   

  NM_018455      *BACH1*             BTB domain and CNC homolog 1                                    12.79754            GO:0000083\~regulation of transcription involved in G1/S transition of mitotic cell cycle,\                                                         GO:0005634\~nucleus,\                                 GO:0001078\~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence‐specific binding,\
                                                                                                                         GO:0000117\~regulation of transcription involved in G2/M transition of mitotic cell cycle,\                                                         GO:0005737\~cytoplasm,\                               GO:0001205\~transcriptional activator activity, RNA polymerase II distal enhancer sequence‐specific binding,\
                                                                                                                         GO:0006281\~DNA repair,\                                                                                                                            GO:0005829\~cytosol,\                                 GO:0001206\~transcriptional repressor activity, RNA polymerase II distal enhancer sequence‐specific binding,\
                                                                                                                         GO:0006355\~regulation of transcription                                                                                                             GO:0031463\~Cul3‐RING ubiquitin ligase complex        GO:0003700\~transcription factor activity, sequence‐specific DNA binding,\
                                                                                                                                                                                                                                                                                                                                   GO:0004842\~ubiquitin‐protein transferase activity

  NM_021023      *NFE2L2*            Nuclear factor, erythroid 2 like 2                              11.75957            GO:0006351\~transcription,\                                                                                                                         GO:0000785\~chromatin,\                               GO:0000980\~RNA polymerase II distal enhancer sequence‐specific DNA binding,\
                                                                                                                         GO:0006954\~inflammatory response,\                                                                                                                 GO:0005634\~nucleus,\                                 GO:0001102\~RNA polymerase II activating transcription factor binding,\
                                                                                                                         GO:0010628\~positive regulation of gene expression,\                                                                                                GO:0005737\~cytoplasm,\                               GO:0001205\~transcriptional activator activity, RNA polymerase II distal enhancer sequence‐specific binding,\
                                                                                                                         GO:0016567\~protein ubiquitination,\                                                                                                                GO:0005813\~centrosome,\                              GO:0003677\~DNA binding,\
                                                                                                                         GO:0030194\~positive regulation of blood coagulation,\                                                                                              GO:0005886\~plasma membrane,\                         GO:0005515\~protein binding
                                                                                                                         GO:0030968\~endoplasmic reticulum unfolded protein response,\                                                                                       GO:0032993\~protein‐DNA complex                       
                                                                                                                         GO:0034599\~cellular response to oxidative stress,\                                                                                                                                                       
                                                                                                                         GO:0036003\~positive regulation of transcription from RNA polymerase II promoter in response to stress,\                                                                                                  
                                                                                                                         GO:0036499\~PERK‐mediated unfolded protein response,\                                                                                                                                                     
                                                                                                                         GO:0042149\~cellular response to glucose starvation,\                                                                                                                                                     
                                                                                                                         GO:0045766\~positive regulation of angiogenesis,\                                                                                                                                                         
                                                                                                                         GO:0071356\~cellular response to tumor necrosis factor,\                                                                                                                                                  
                                                                                                                         GO:0071456\~cellular response to hypoxia,\                                                                                                                                                                
                                                                                                                         GO:0071498\~cellular response to fluid shear stress,\                                                                                                                                                     
                                                                                                                         GO:1902037\~negative regulation of hematopoietic stem cell differentiation,\                                                                                                                              
                                                                                                                         GO:1903071\~positive regulation of ER‐associated ubiquitin‐dependent protein catabolic process,\                                                                                                          
                                                                                                                         GO:1903788\~positive regulation of glutathione biosynthetic process                                                                                                                                       

  NM_080387      *TET2*              Tet methylcytosine dioxygenase 2                                11.42427            GO:0001822\~kidney development,\                                                                                                                    GO:0005634\~nucleus                                   GO:0000907\~sulfonate dioxygenase activity,GO:0003677\~DNA binding,GO:0005515\~protein binding,GO:0008198\~ferrous iron binding,GO:0008270\~zinc ion binding,GO:0018602\~2,4‐dichlorophenoxyacetate alpha‐ketoglutarate dioxygenase activity,GO:0019798\~procollagen‐proline dioxygenase activity,GO:0034792\~hypophosphite dioxygenase activity,GO:0043734\~DNA‐N1‐methyladenine dioxygenase activity,GO:0052634\~C‐19 gibberellin 2‐beta‐dioxygenase activity,GO:0052635\~C‐20 gibberellin 2‐beta‐dioxygenase activity,GO:0070579\~methylcytosine dioxygenase activity
                                                                                                                         GO:0002318\~myeloid progenitor cell differentiation,\                                                                                                                                                     
                                                                                                                         GO:0006211\~5‐methylcytosine catabolic process,\                                                                                                                                                          
                                                                                                                         GO:0006493\~protein O‐linked glycosylation,\                                                                                                                                                              
                                                                                                                         GO:0007049\~cell cycle,\                                                                                                                                                                                  
                                                                                                                         GO:0014070\~response to organic cyclic compound,\                                                                                                                                                         
                                                                                                                         GO:0020027\~hemoglobin metabolic process,\                                                                                                                                                                
                                                                                                                         GO:0030099\~myeloid cell differentiation,\                                                                                                                                                                
                                                                                                                         GO:0045944\~positive regulation of transcription from RNA polymerase II promoter,\                                                                                                                        
                                                                                                                         GO:0061484\~hematopoietic stem cell homeostasis,\                                                                                                                                                         
                                                                                                                         GO:0070989\~oxidative demethylation,\                                                                                                                                                                     
                                                                                                                         GO:0080111\~DNA demethylation,\                                                                                                                                                                           
                                                                                                                         GO:0080182\~histone H3‐K4 trimethylation                                                                                                                                                                  

  NM_000494      *MBTPS2*            Membrane bound transcription factor peptidase, site 2           11.32147            GO:0008203\~cholesterol metabolic process,\                                                                                                         GO:0000139\~Golgi membrane\                           GO:0004222\~metalloendopeptidase activity,\
                                                                                                                         GO:0031293\~membrane protein intracellular domain proteolysis,\                                                                                     ,GO:0005737\~cytoplasm,\                              GO:0008237\~metallopeptidase activity,\
                                                                                                                         GO:0034976\~response to endoplasmic reticulum stress,\                                                                                              GO:0016021\~integral component of membrane            GO:0046872\~metal ion binding
                                                                                                                         GO:0036500\~ATF6‐mediated unfolded protein response,\                                                                                                                                                     
                                                                                                                         GO:0051091\~positive regulation of sequence‐specific DNA binding transcription factor activity,\                                                                                                          
                                                                                                                         GO:1990440\~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress                                                                              

  NM_016230      *C2orf81*           Chromosome 2 open reading frame 81                              8.747677            ---                                                                                                                                                 ---                                                   ---

  NM_001195215   *PPP1R13L*          Protein phosphatase 1 regulatory subunit 13 like                8.60306             GO:0000122\~negative regulation of transcription from RNA polymerase II promoter,\                                                                  GO:0005634\~nucleus,\                                 GO:0003714\~transcription corepressor activity,\
                                                                                                                         GO:0006351\~transcription, DNA‐templated,\                                                                                                          GO:0005737\~cytoplasm,\                               GO:0005515\~protein binding,\
                                                                                                                         GO:0006915\~apoptotic process,\                                                                                                                     GO:0005913\~cell‐cell adherens junction,\             GO:0008134\~transcription factor binding,\
                                                                                                                         GO:0045597\~positive regulation of cell differentiation,\                                                                                           GO:0030054\~cell junction,\                           GO:0042802\~identical protein binding,\
                                                                                                                         GO:0098609\~cell‐cell adhesion,\                                                                                                                    GO:0045171\~intercellular bridge                      GO:0098641\~cadherin binding involved in cell‐cell adhesion
                                                                                                                         GO:1901796\~regulation of signal transduction by p53 class mediator                                                                                                                                       

  NM_024693      *AKR1B1*            Aldo‐keto reductase family 1 member B                           8.005092            GO:0001894\~tissue homeostasis,\                                                                                                                    GO:0005615\~extracellular space,\                     GO:0004032\~alditol:NADP+ 1‐oxidoreductase activity,\
                                                                                                                         GO:0005975\~carbohydrate metabolic process,\                                                                                                        GO:0005654\~nucleoplasm,\                             GO:0004033\~aldo‐keto reductase (NADP) activity,\
                                                                                                                         GO:0006700\~C21‐steroid hormone biosynthetic process,\                                                                                              GO:0005737\~cytoplasm,\                               GO:0009055\~electron carrier activity,\
                                                                                                                         GO:0006950\~response to stress,\                                                                                                                    GO:0005829\~cytosol,\                                 GO:0016491\~oxidoreductase activity,\
                                                                                                                         GO:0042415\~norepinephrine metabolic process,\                                                                                                      GO:0033010\~paranodal junction,\                      GO:0043795\~glyceraldehyde oxidoreductase activity
                                                                                                                         GO:0046427\~positive regulation of JAK‐STAT cascade,\                                                                                               GO:0042629\~mast cell granule,\                       
                                                                                                                         GO:0048661\~positive regulation of smooth muscle cell proliferation,\                                                                               GO:0043220\~Schmidt‐Lanterman incisure,\              
                                                                                                                         GO:0055114\~oxidation‐reduction process,\                                                                                                           GO:0048471\~perinuclear region of cytoplasm,\         
                                                                                                                         GO:0070301\~cellular response to hydrogen peroxide                                                                                                  GO:0070062\~extracellular exosome                     

  NM_001776      *COL17A1*           Collagen type XVII alpha 1 chain                                7.970873            GO:0007160\~cell‐matrix adhesion,\                                                                                                                  GO:0005576\~extracellular region,\                    GO:0005515\~protein binding
                                                                                                                         GO:0008544\~epidermis development,\                                                                                                                 GO:0005578\~proteinaceous extracellular matrix,\      
                                                                                                                         GO:0031581\~hemidesmosome assembly,\                                                                                                                GO:0005581\~collagen trimer,\                         
                                                                                                                         GO:0050776\~regulation of immune response                                                                                                           GO:0005604\~basement membrane,\                       
                                                                                                                                                                                                                                                                             GO:0005788\~endoplasmic reticulum lumen,\             
                                                                                                                                                                                                                                                                             GO:0005886\~plasma membrane,\                         
                                                                                                                                                                                                                                                                             GO:0005911\~cell‐cell junction\                       
                                                                                                                                                                                                                                                                             GO:0030056\~hemidesmosome                             

  NM_016613      *MCMBP*             Minichromosome maintenance complex binding protein              7.570634            GO:0006261\~DNA‐dependent DNA replication,\                                                                                                         GO:0000790\~nuclear chromatin,\                       GO:0003682\~chromatin binding,\
                                                                                                                         GO:0007062\~sister chromatid cohesion,\                                                                                                             GO:0005654\~nucleoplasm,\                             GO:0005515\~protein binding
                                                                                                                         GO:0007067\~mitotic nuclear division,\                                                                                                              GO:0005737\~cytoplasm,\                               
                                                                                                                         GO:0051301\~cell division                                                                                                                           GO:0005886\~plasma membrane,\                         
                                                                                                                                                                                                                                                                             GO:0042555\~MCM complex                               

  NM_016623      *FAR1*              Fatty acyl‐CoA reductase 1                                      7.238576            GO:0006086\~acetyl‐CoA biosynthetic process from pyruvate,\                                                                                         GO:0005777\~peroxisome,\                              GO:0016491\~oxidoreductase activity,\
                                                                                                                         GO:0008611\~ether lipid biosynthetic process,\                                                                                                      GO:0005778\~peroxisomal membrane,\                    GO:0050062\~long‐chain‐fatty‐acyl‐CoA reductase activity,\
                                                                                                                         GO:0010025\~wax biosynthetic process,\                                                                                                              GO:0005782\~peroxisomal matrix,\                      GO:0052814\~medium‐chain‐aldehyde dehydrogenase activity,\
                                                                                                                         GO:0035336\~long‐chain fatty‐acyl‐CoA metabolic process,\                                                                                           GO:0016021\~integral component of membrane            GO:0080019\~fatty‐acyl‐CoA reductase (alcohol‐forming) activity
                                                                                                                         GO:0046474\~glycerophospholipid biosynthetic process,\                                                                                                                                                    
                                                                                                                         GO:0055114\~oxidation‐reduction process                                                                                                                                                                   

  NM_032228      *OSBPL8*            Oxysterol binding protein like 8                                6.956427            GO:0006869\~lipid transport,\                                                                                                                       GO:0005783\~endoplasmic reticulum,\                   GO:0001786\~phosphatidylserine binding,\
                                                                                                                         GO:0010891\~negative regulation of sequestering of triglyceride,\                                                                                   GO:0016020\~membrane,\                                GO:0005548\~phospholipid transporter activity,\
                                                                                                                         GO:0030336\~negative regulation of cell migration,\                                                                                                 GO:0031965\~nuclear membrane,\                        GO:0015485\~cholesterol binding,\
                                                                                                                         GO:0032148\~activation of protein kinase B activity,\                                                                                               GO:0032541\~cortical endoplasmic reticulum            GO:0070273\~phosphatidylinositol‐4‐phosphate binding
                                                                                                                         GO:0045444\~fat cell differentiation,\                                                                                                                                                                    
                                                                                                                         GO:0046628\~positive regulation of insulin receptor signaling pathway,\                                                                                                                                   
                                                                                                                         GO:0090204\~protein localization to nuclear pore                                                                                                                                                          

  NM_006682      *ZMPSTE24*          Zinc metallopeptidase STE24                                     6.555173            GO:0006508\~proteolysis,\                                                                                                                           GO:0005637\~nuclear inner membrane,\                  GO:0004222\~metalloendopeptidase activity,\
                                                                                                                         GO:0006998\~nuclear envelope organization,\                                                                                                         GO:0005789\~endoplasmic reticulum membrane,\          GO:0008235\~metalloexopeptidase activity,\
                                                                                                                         GO:0030327\~prenylated protein catabolic process,\                                                                                                  GO:0016020\~membrane,\                                GO:0046872\~metal ion binding
                                                                                                                         GO:0071586\~CAAX‐box protein processing                                                                                                             GO:0070062\~extracellular exosome                     

  NM_022763      *CCNYL1*            Cyclin Y like 1                                                 6.300126            GO:0000079\~regulation of cyclin‐dependent protein serine/threonine kinase activity                                                                 GO:0005886\~plasma membrane                           GO:0005515\~protein binding,\
                                                                                                                                                                                                                                                                                                                                   GO:0019901\~protein kinase binding

  NM_003838      *RRAGD*             Ras related GTP binding D                                       6.236001            GO:0007050\~cell cycle arrest,\                                                                                                                     GO:0005634\~nucleus,\                                 GO:0003924\~GTPase activity,\
                                                                                                                         GO:0009267\~cellular response to starvation,\                                                                                                       GO:0005737\~cytoplasm,\                               GO:0005515\~protein binding,\
                                                                                                                         GO:0010506\~regulation of autophagy,\                                                                                                               GO:0005764\~lysosome,\                                GO:0005525\~GTP binding,\
                                                                                                                         GO:0016236\~macroautophagy,\                                                                                                                        GO:0005829\~cytosol,\                                 GO:0046982\~protein heterodimerization activity
                                                                                                                         GO:0032008\~positive regulation of TOR signaling,\                                                                                                  GO:0034448\~EGO complex,\                             
                                                                                                                         GO:0071230\~cellular response to amino acid stimulus                                                                                                GO:1990131\~Gtr1‐Gtr2 GTPase complex                  

  NM_003774      *GALNT4*            Polypeptide N‐acetylgalactosaminyltransferase 4                 6.227974            GO:0005975\~carbohydrate metabolic process,\                                                                                                        GO:0005794\~Golgi apparatus,\                         GO:0004653\~polypeptide N‐acetylgalactosaminyltransferase activity,\
                                                                                                                         GO:0016266\~O‐glycan processing                                                                                                                     GO:0016021\~integral component of membrane,\          GO:0030246\~carbohydrate binding,\
                                                                                                                                                                                                                                                                             GO:0048471\~perinuclear region of cytoplasm,\         GO:0046872\~metal ion binding
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome                     

  NM_015473      *UBE2W*             Ubiquitin conjugating enzyme E2 W (putative)                    5.881697            GO:0006281\~DNA repair,\                                                                                                                            GO:0005634\~nucleus,\                                 GO:0004842\~ubiquitin‐protein transferase activity,\
                                                                                                                         GO:0006513\~protein monoubiquitination,\                                                                                                            GO:0005737\~cytoplasm,\                               GO:0005515\~protein binding,\
                                                                                                                         GO:0071218\~cellular response to misfolded protein                                                                                                  GO:0016021\~integral component of membrane            GO:0005524\~ATP binding

  NM_006410      *HEATR5A*           HEAT repeat containing 5A                                       5.784991            ---                                                                                                                                                 ---                                                   ---

  NM_000416      *UBE4A*             Ubiquitination factor E4A                                       5.612217            GO:0000209\~protein polyubiquitination,\                                                                                                            GO:0000151\~ubiquitin ligase complex,\                GO:0004114\~3',5'‐cyclic‐nucleotide phosphodiesterase activity,\
                                                                                                                         GO:0007165\~signal transduction,\                                                                                                                   GO:0005634\~nucleus,\                                 GO:0005515\~protein binding,\
                                                                                                                         GO:0030433\~ER‐associated ubiquitin‐dependent protein catabolic process                                                                             GO:0005737\~cytoplasm                                 GO:0016874\~ligase activity,\
                                                                                                                                                                                                                                                                                                                                   GO:0034450\~ubiquitin‐ubiquitin ligase activity

  NM_201612      *ABI1*              Abl interactor 1                                                5.533139            GO:0006928\~movement of cell or subcellular component,\                                                                                             GO:0005622\~intracellular,\                           GO:0005515\~protein binding,\
                                                                                                                         GO:0007169\~transmembrane receptor protein tyrosine kinase signaling pathway,\                                                                      GO:0005634\~nucleus,\                                 GO:0008092\~cytoskeletal protein binding,\
                                                                                                                         GO:0008154\~actin polymerization or depolymerization,\                                                                                              GO:0005737\~cytoplasm,\                               GO:0017124\~SH3 domain binding,\
                                                                                                                         GO:0008285\~negative regulation of cell proliferation,\                                                                                             GO:0005783\~endoplasmic reticulum,\                   GO:0030296\~protein tyrosine kinase activator activity,\
                                                                                                                         GO:0016032\~viral process,\                                                                                                                         GO:0005856\~cytoskeleton,\                            GO:0032403\~protein complex binding,\
                                                                                                                         GO:0018108\~peptidyl‐tyrosine phosphorylation,\                                                                                                     GO:0005913\~cell‐cell adherens junction,\             GO:0098641\~cadherin binding involved in cell‐cell adhesion
                                                                                                                         GO:0035855\~megakaryocyte development,\                                                                                                             GO:0030027\~lamellipodium,\                           
                                                                                                                         GO:0038096\~Fc‐gamma receptor signaling pathway involved in phagocytosis,\                                                                          GO:0030175\~filopodium,\                              
                                                                                                                         GO:0048010\~vascular endothelial growth factor receptor signaling pathway,\                                                                         GO:0030426\~growth cone,\                             
                                                                                                                         GO:0061098\~positive regulation of protein tyrosine kinase activity,\                                                                               GO:0031209\~SCAR complex,\                            
                                                                                                                         GO:0072673\~lamellipodium morphogenesis,\                                                                                                           GO:0045211\~postsynaptic membrane,\                   
                                                                                                                         GO:0098609\~cell‐cell adhesion                                                                                                                      GO:0070062\~extracellular exosome                     

  NM_005566      *PPIH*              Peptidylprolyl isomerase H                                      5.40687             GO:0000398\~mRNA splicing, via spliceosome,\                                                                                                        GO:0005654\~nucleoplasm,\                             GO:0003755\~peptidyl‐prolyl cis‐trans isomerase activity,\
                                                                                                                         GO:0000413\~protein peptidyl‐prolyl isomerization,\                                                                                                 GO:0005681\~spliceosomal complex,\                    GO:0005515\~protein binding,\
                                                                                                                         GO:0006457\~protein folding,\                                                                                                                       GO:0005737\~cytoplasm,\                               GO:0016018\~cyclosporin A binding,\
                                                                                                                         GO:0006461\~protein complex assembly,\                                                                                                              GO:0016607\~nuclear speck,\                           GO:0043021\~ribonucleoprotein complex binding
                                                                                                                         GO:0045070\~positive regulation of viral genome replication                                                                                         GO:0046540\~U4/U6 x U5 tri‐snRNP complex,\            
                                                                                                                                                                                                                                                                             GO:0071001\~U4/U6 snRNP                               

  NM_005767      *CENPN*             Centromere protein N                                            4.732161            GO:0007059\~chromosome segregation,\                                                                                                                GO:0000775\~chromosome, centromeric region,\          ---
                                                                                                                         GO:0007062\~sister chromatid cohesion,\                                                                                                             GO:0000777\~condensed chromosome kinetochore,\        
                                                                                                                         GO:0007067\~mitotic nuclear division,\                                                                                                              GO:0005654\~nucleoplasm,\                             
                                                                                                                         GO:0034080\~CENP‐A containing nucleosome assembly,\                                                                                                 GO:0005829\~cytosol                                   
                                                                                                                         GO:0034508\~centromere complex assembly                                                                                                                                                                   

  NM_015884      *MIER1*             MIER1 transcriptional regulator                                 4.196767            GO:0006351\~transcription, DNA‐templated,\                                                                                                          GO:0005654\~nucleoplasm,\                             GO:0003677\~DNA binding,\
                                                                                                                         GO:0007165\~signal transduction,\                                                                                                                   GO:0005737\~cytoplasm,\                               GO:0004871\~signal transducer activity,\
                                                                                                                         GO:0031937\~positive regulation of chromatin silencing,\                                                                                            GO:0017053\~transcriptional repressor complex         GO:0005515\~protein binding
                                                                                                                         GO:0043123\~positive regulation of I‐kappaB kinase/NF‐kappaB signaling                                                                                                                                    

  NM_024834      *IKBIP*             IKBKB interacting protein                                       −4.35974            GO:0010165\~response to X‐ray                                                                                                                       GO:0005783\~endoplasmic reticulum,\                   GO:0005515\~protein binding
                                                                                                                                                                                                                                                                             GO:0016020\~membrane                                  

  NM_020948      *SLC22A15*          Solute carrier family 22 member 15                              −5.63841            GO:0006811\~ion transport,\                                                                                                                         GO:0016021\~integral component of membrane            GO:0022857\~transmembrane transporter activity,\
                                                                                                                         GO:0055085\~transmembrane transport                                                                                                                                                                       GO:0022891\~substrate‐specific transmembrane transporter activity

  NM_001031716   *IFNGR1*            Interferon gamma receptor 1                                     −6.31219            GO:0007165\~signal transduction,\                                                                                                                   GO:0005783\~endoplasmic reticulum,\                   GO:0004906\~interferon‐gamma receptor activity,\
                                                                                                                         GO:0009615\~response to virus,\                                                                                                                     GO:0005886\~plasma membrane,\                         GO:0005515\~protein binding,\
                                                                                                                         GO:0060333\~interferon‐gamma‐mediated signaling pathway,\                                                                                           GO:0030425\~dendrite,\                                GO:0042015\~interleukin‐20 binding
                                                                                                                         GO:0060334\~regulation of interferon‐gamma‐mediated signaling pathway                                                                               GO:0031982\~vesicle                                   

  NM_006164      *CFHR3*             Complement factor H related 3                                   −6.547              ---                                                                                                                                                 GO:0005615\~extracellular space,\                      
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome,\                   
                                                                                                                                                                                                                                                                             GO:0072562\~blood microparticle                       

  NM_020841      *ENTPD1*            Ectonucleoside triphosphate diphosphohydrolase 1                −7.19342            GO:0007155\~cell adhesion,\                                                                                                                         GO:0005886\~plasma membrane,\                         GO:0005515\~protein binding,\
                                                                                                                         GO:0007596\~blood coagulation                                                                                                                       GO:0016020\~membrane,\                                GO:0005524\~ATP binding,\
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome                     GO:0016787\~hydrolase activity

  NM_006347      *CLEC4D*            C‐type lectin domain family 4 member D                          −7.20897            GO:0002223\~stimulatory C‐type lectin receptor signaling pathway,\                                                                                  GO:0005886\~plasma membrane,\                         GO:0030246\~carbohydrate binding,\
                                                                                                                         GO:0002250\~adaptive immune response,\                                                                                                              GO:0016021\~integral component of membrane            GO:0034987\~immunoglobulin receptor binding
                                                                                                                         GO:0002292\~T cell differentiation involved in immune response,\                                                                                                                                          
                                                                                                                         GO:0038094\~Fc‐gamma receptor signaling pathway,\                                                                                                                                                         
                                                                                                                         GO:0045087\~innate immune response                                                                                                                                                                        

  NM_006663      *USP15*             Ubiquitin specific peptidase 15                                 −7.21872            GO:0006511\~ubiquitin‐dependent protein catabolic process,\                                                                                         GO:0005634\~nucleus,\                                 GO:0004197\~cysteine‐type endopeptidase activity,\
                                                                                                                         GO:0007179\~transforming growth factor beta receptor signaling pathway,\                                                                            GO:0005737\~cytoplasm                                 GO:0004843\~thiol‐dependent ubiquitin‐specific protease activity,\
                                                                                                                         GO:0030509\~BMP signaling pathway,\                                                                                                                                                                       GO:0005160\~transforming growth factor beta receptor binding,\
                                                                                                                         GO:0035616\~histone H2B conserved C‐terminal lysine deubiquitination,\                                                                                                                                    GO:0005515\~protein binding,\
                                                                                                                         GO:0060389\~pathway‐restricted SMAD protein phosphorylation                                                                                                                                               GO:0046332\~SMAD binding,\
                                                                                                                                                                                                                                                                                                                                   GO:0061649\~ubiquitinated histone binding

  NM_018699      *SLFN12*            Schlafen family member 12                                       −7.8338             ---                                                                                                                                                 ---                                                   GO:0005524\~ATP binding

  NM_002838      *FGL2*              Fibrinogen like 2                                               −8.25242            GO:0006508\~proteolysis                                                                                                                             GO:0005577\~fibrinogen complex,\                      GO:0008233\~peptidase activity
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome                     

  NM_016131      *ACSL3*             Acyl‐CoA synthetase long‐chain family member 3                  −8.30246            GO:0001676\~long‐chain fatty acid metabolic process,\                                                                                               GO:0005741\~mitochondrial outer membrane,\            GO:0003824\~catalytic activity,\
                                                                                                                         GO:0006633\~fatty acid biosynthetic process,\                                                                                                       GO:0005778\~peroxisomal membrane,\                    GO:0004467\~long‐chain fatty acid‐CoA ligase activity,\
                                                                                                                         GO:0008152\~metabolic process,\                                                                                                                     GO:0005783\~endoplasmic reticulum,\                   GO:0005524\~ATP binding,GO:0016874\~ligase activity,\
                                                                                                                         GO:0014070\~response to organic cyclic compound,\                                                                                                   GO:0005789\~endoplasmic reticulum membrane,\          GO:0019901\~protein kinase binding,\
                                                                                                                         GO:0034379\~very‐low‐density lipoprotein particle assembly,\                                                                                        GO:0005794\~Golgi apparatus,\                         GO:0019904\~protein domain specific binding,\
                                                                                                                         GO:0042998\~positive regulation of Golgi to plasma membrane protein transport,\                                                                     GO:0005811\~lipid particle,\                          GO:0102391\~decanoate‐CoA ligase activity
                                                                                                                         GO:0044539\~long‐chain fatty acid import,\                                                                                                          GO:0016020\~membrane,\                                
                                                                                                                         GO:0051047\~positive regulation of secretion,\                                                                                                      GO:0048471\~perinuclear region of cytoplasm           
                                                                                                                         GO:2001247\~positive regulation of phosphatidylcholine biosynthetic process                                                                                                                               

  NM_001003      *ZEB2*              Zinc finger E‐box binding homeobox 2                            −8.42855            GO:0000122\~negative regulation of transcription from RNA polymerase II promoter,\                                                                  GO:0005634\~nucleus                                   GO:0001227\~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence‐specific binding,\
                                                                                                                         GO:0006351\~transcription, DNA‐templated,\                                                                                                                                                                GO:0003676\~nucleic acid binding,\
                                                                                                                         GO:0048066\~developmental pigmentation,\                                                                                                                                                                  GO:0005515\~protein binding,\
                                                                                                                         GO:0050790\~regulation of catalytic activity,GO:0097324\~melanocyte migration                                                                                                                             GO:0019208\~phosphatase regulator activity,\
                                                                                                                                                                                                                                                                                                                                   GO:0046872\~metal ion binding

  NM_021244      *FPGT*              Fucose‐1‐phosphate guanylyltransferase                          −8.48534            GO:0006004\~fucose metabolic process                                                                                                                GO:0005737\~cytoplasm\                                GO:0003824\~catalytic activity,\
                                                                                                                                                                                                                                                                             GO:0005829\~cytosol                                   GO:0005525\~GTP binding,\
                                                                                                                                                                                                                                                                                                                                   GO:0016772\~transferase activity, transferring phosphorus‐containing groups,\
                                                                                                                                                                                                                                                                                                                                   GO:0016779\~nucleotidyltransferase activity,\
                                                                                                                                                                                                                                                                                                                                   GO:0047341\~fucose‐1‐phosphate guanylyltransferase activity

  NM_018420      *ECHDC3*            Enoyl‐CoA hydratase domain containing 3                         −8.66068            GO:0008152\~metabolic process                                                                                                                       GO:0005739\~mitochondrion                             GO:0003824\~catalytic activity

  NM_080546      *PRDM5*             PR/SET domain 5                                                 −8.77508            GO:0000122\~negative regulation of transcription from RNA polymerase II promoter,\                                                                  GO:0005634\~nucleus                                   GO:0001078\~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence‐specific binding,\
                                                                                                                         GO:0000278\~mitotic cell cycle,\                                                                                                                                                                          GO:0003676\~nucleic acid binding,\
                                                                                                                         GO:0006351\~transcription, DNA‐templated,\                                                                                                                                                                GO:0005515\~protein binding,\
                                                                                                                         GO:0016575\~histone deacetylation,\                                                                                                                                                                       GO:0008168\~methyltransferase activity,\
                                                                                                                         GO:0045892\~negative regulation of transcription, DNA‐templated,\                                                                                                                                         GO:0044212\~transcription regulatory region DNA binding,\
                                                                                                                         GO:0051567\~histone H3‐K9 methylation                                                                                                                                                                     GO:0046872\~metal ion binding,\
                                                                                                                                                                                                                                                                                                                                   GO:0070491\~repressing transcription factor binding

  NM_018042      *FAM49B*            Family with sequence similarity 49 member B                     −8.78217            ---                                                                                                                                                 GO:0005929\~cilium,\                                  GO:0005515\~protein binding
                                                                                                                                                                                                                                                                             GO:0016020\~membrane,\                                
                                                                                                                                                                                                                                                                             GO:0070062\~extracellular exosome                     

  NM_018079      *VPS51 (C11orf2)*   VPS51, GARP complex subunit                                     −8.85243            GO:0006869\~lipid transport,\                                                                                                                       GO:0000938\~GARP complex,\                            GO:0005515\~protein binding
                                                                                                                         GO:0006914\~autophagy,\                                                                                                                             GO:0005794\~Golgi apparatus,\                         
                                                                                                                         GO:0007041\~lysosomal transport,\                                                                                                                   GO:0005829\~cytosol,\                                 
                                                                                                                         GO:0015031\~protein transport,\                                                                                                                     GO:0016020\~membrane,\                                
                                                                                                                         GO:0032456\~endocytic recycling,\                                                                                                                   GO:0016021\~integral component of membrane,\          
                                                                                                                         GO:0042147\~retrograde transport, endosome to Golgi                                                                                                 GO:0055037\~recycling endosome,\                      
                                                                                                                                                                                                                                                                             GO:1990745\~EARP complex                              

  NM_017628      *DENND1B*           DENN domain containing 1B                                       −10.4299            GO:0015031\~protein transport,\                                                                                                                     GO:0005829\~cytosol,\                                 GO:0017112\~Rab guanyl‐nucleotide exchange factor activity,\
                                                                                                                         GO:0032456\~endocytic recycling,\                                                                                                                   GO:0030136\~clathrin‐coated vesicle                   GO:0017137\~Rab GTPase binding
                                                                                                                         GO:0035745\~T‐helper 2 cell cytokine production,\                                                                                                                                                         
                                                                                                                         GO:0043547\~positive regulation of GTPase activity,\                                                                                                                                                      
                                                                                                                         GO:0050776\~regulation of immune response,\                                                                                                                                                               
                                                                                                                         GO:0050852\~T cell receptor signaling pathway                                                                                                                                                             

  NM_003260      *NABP1 (OBFC2A)*    Nucleic acid binding protein 1                                  −11.0293            GO:0006281\~DNA repair,\                                                                                                                            GO:0000784\~nuclear chromosome, telomeric region,\    GO:0003697\~single‐stranded DNA binding,\
                                                                                                                         GO:0006974\~cellular response to DNA damage stimulus,\                                                                                              GO:0005737\~cytoplasm,\                               GO:0003723\~RNA binding,\
                                                                                                                         GO:0007093\~mitotic cell cycle checkpoint,\                                                                                                         GO:0070876\~SOSS complex                              GO:0005515\~protein binding
                                                                                                                         GO:0010212\~response to ionizing radiation,\                                                                                                                                                              
                                                                                                                         GO:0042795\~snRNA transcription from RNA polymerase II promoter                                                                                                                                           

  NM_018299      *CYB5R4*            Cytochrome b5 reductase 4                                       −11.661             GO:0003032\~detection of oxygen,\                                                                                                                   GO:0005783\~endoplasmic reticulum,\                   GO:0004128\~cytochrome‐b5 reductase activity, acting on NAD(P)H,\
                                                                                                                         GO:0006091\~generation of precursor metabolites and energy,\                                                                                        GO:0048471\~perinuclear region of cytoplasm           GO:0016174\~NAD(P)H oxidase activity,\
                                                                                                                         GO:0006801\~superoxide metabolic process,\                                                                                                                                                                GO:0016653\~oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,\
                                                                                                                         GO:0015701\~bicarbonate transport,\                                                                                                                                                                       GO:0020037\~heme binding,\
                                                                                                                         GO:0030073\~insulin secretion,\                                                                                                                                                                           GO:0046872\~metal ion binding,\
                                                                                                                         GO:0042593\~glucose homeostasis,\                                                                                                                                                                         GO:0071949\~FAD binding
                                                                                                                         GO:0048468\~cell development\                                                                                                                                                                             
                                                                                                                         ,GO:0055114\~oxidation‐reduction process                                                                                                                                                                  

  NM_004788      *LPAR6*             Lysophosphatidic acid receptor 6                                −11.9776            GO:0035025\~positive regulation of Rho protein signal transduction,\                                                                                GO:0005886\~plasma membrane,\                         GO:0004930\~G‐protein coupled receptor activity,\
                                                                                                                         GO:0051482\~positive regulation of cytosolic calcium ion concentration involved in phospholipase C‐activating G‐protein coupled signaling pathway   GO:0005887\~integral component of plasma membrane,\   GO:0070915\~lysophosphatidic acid receptor activity
                                                                                                                                                                                                                                                                             GO:0016021\~integral component of membrane            

  NM_006313      *SRBD1*             S1 RNA binding domain 1                                         −12.4726            GO:0006139\~nucleobase‐containing compound metabolic process                                                                                        ---                                                   GO:0003723\~RNA binding

  NM_013265      *B3GNT5*            UDP‐GlcNAc:betaGal beta‐1,3‐N‐acetylglucosaminyltransferase 5   −12.6434            GO:0006486\~protein glycosylation,\                                                                                                                 GO:0000139\~Golgi membrane,\                          GO:0008378\~galactosyltransferase activity,GO:0008457\~beta‐galactosyl‐N‐acetylglucosaminylgalactosylglucosyl‐ceramide beta‐1,3‐acetylglucosaminyltransferase activity,\
                                                                                                                         GO:0007417\~central nervous system development,\                                                                                                    GO:0005622\~intracellular,\                           GO:0008499\~UDP‐galactose:beta‐N‐acetylglucosamine beta‐1,3‐galactosyltransferase activity,\
                                                                                                                         GO:0009247\~glycolipid biosynthetic process                                                                                                         GO:0016021\~integral component of membrane            GO:0047256\~lactosylceramide 1,3‐N‐acetyl‐beta‐D‐glucosaminyltransferase activity

  NM_015626      *FAM198B*           Family with sequence similarity 198 member B                    −13.2931            ---                                                                                                                                                 GO:0000139\~Golgi membrane,\                          ---
                                                                                                                                                                                                                                                                             GO:0005794\~Golgi apparatus                           

  NM_014795      *WSB1*              WD repeat and SOCS box containing 1                             −13.4219            GO:0000209\~protein polyubiquitination,\                                                                                                            GO:0005622\~intracellular,\                           GO:0004842\~ubiquitin‐protein transferase activity,\
                                                                                                                         GO:0016567\~protein ubiquitination,\                                                                                                                GO:0005829\~cytosol                                   GO:0005515\~protein binding
                                                                                                                         GO:0035556\~intracellular signal transduction                                                                                                                                                             

  NM_005857      *ATP11B*            ATPase phospholipid transporting 11B (putative)                 −16.3131            GO:0006811\~ion transport,\                                                                                                                         GO:0005637\~nuclear inner membrane,\                  GO:0000287\~magnesium ion binding,\
                                                                                                                         GO:0015917\~aminophospholipid transport,\                                                                                                           GO:0005769\~early endosome,\                          GO:0004012\~phospholipid‐translocating ATPase activity,\
                                                                                                                         GO:0034220\~ion transmembrane transport,\                                                                                                           GO:0005783\~endoplasmic reticulum,\                   GO:0005515\~protein binding,\
                                                                                                                         GO:0045332\~phospholipid translocation                                                                                                              GO:0005794\~Golgi apparatus,\                         GO:0005524\~ATP binding,\
                                                                                                                                                                                                                                                                             GO:0005886\~plasma membrane,\                         GO:0015075\~ion transmembrane transporter activity
                                                                                                                                                                                                                                                                             GO:0016020\~membrane,\                                
                                                                                                                                                                                                                                                                             GO:0055037\~recycling endosome                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---, no data available.
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As a final classifier, obtained through application of the classification algorithm based on 56 genes to all 55 subjects, we obtained the following equation for PDAC diagnosis using the weighted linear sum of each gene\'s expression level:

$$\begin{array}{cl}
 & {\text{Sum‐value} =} \\
 & {\text{intercept} + a_{1} \ast \text{gene}1 + a_{2} \ast \text{gene}2 + \ldots\ldots + a_{56} \ast \ast \text{gene}56} \\
\end{array}$$

In the formula above, a~n~ is a coefficient value for each gene (Table [1](#cas13971-tbl-0001){ref-type="table"}); "a1\*gene 1 + a2\*gene 2 + ......... + a56\*\*gene 56" was determined based on Fisher\'s linear discriminant, and its threshold was 209.018. To simplify the threshold value as zero by the formula, intercept value, −209.018, in the equation, was mounted. Thus, sum‐values 0 or higher and less than 0 were taken as positive and negative for PDAC, respectively.

3.2. Characteristics of subjects registered in the clinical study used to assess the performance of blood mRNA screening system {#cas13971-sec-0010}
-------------------------------------------------------------------------------------------------------------------------------

We designed a clinical study to assess the performance of the blood mRNA screening system. The study cohort consisted of 54 patients with PDAC, 25 with IPMN, 22 with chronic pancreatitis, and 104 noncancer subjects (Figure [1](#cas13971-fig-0001){ref-type="fig"}). All subjects were assessed for suitability for the safety analysis cohort and full analysis set. After applying the exclusion criteria, we finally included 53 patients with PDAC, 23 with IPMN, 22 with chronic pancreatitis, and 102 noncancer subjects.

![Outline of the clinical study to assess the performance of the blood mRNA screening system for pancreatic ductular adenocarcinoma (PDAC). The study cohort consisted of 54 patients with PDAC, 22 with chronic pancreatitis, 25 with intraductal papillary mucinous neoplasm (IPMN), and 104 noncancer subjects. No cases were excluded from the full analysis set. In the per protocol set, 1 PDAC patient, 2 IPMN patients, and 2 noncancer volunteers were excluded. Thus, 53 PDAC patients, 22 chronic pancreatitis patients, 23 IPMN patients, and 102 noncancer subjects were included in the per protocol analysis](CAS-110-1364-g001){#cas13971-fig-0001}

Some of the clinical characteristics, such as age, gender, and body mass index, were different between PDAC patients and noncancer subjects (Table [2](#cas13971-tbl-0002){ref-type="table"}). The frequency of alcohol drinking was not different between PDAC patients and noncancer subjects (Table [2](#cas13971-tbl-0002){ref-type="table"}).

###### 

Clinical characteristics of study subjects to assess the blood mRNA screening system for pancreatic ductal adenocarcinoma (PDAC)

                                 PDAC         Chronic pancreatitis   IPMN          Noncancer
  ------------------------------ ------------ ---------------------- ------------- -------------
  Objective number               53           22                     23            102
  Age (y)                                                                          
  Average                        69.6         61.7                   67.7          63.4
  SD                             10.7         10.8                   8.2           11.4
  Number                         53           22                     23            102
  Wilcoxon signed‐rank test      Ref          *P* = .008             *P* = .399    *P* = .003
                                 ---          Ref                    *P* = .031    *P* = .484
                                 ---          ---                    Ref           *P* = .122
  Gender                                                                           
  Male                           26 (49.1%)   19 (86.4%)             11 (47.8%)    69 (67.6%)
  Female                         27 (50.0%)   3 (13.6%)              12 (52.2%)    33 (32.4%)
  Fisher\'s exact test           Ref          *P* = .004             *P* = 1.000   *P* = .036
                                 ---          Ref                    *P* = .011    *P* = .119
                                 ---          ---                    Ref           *P* = .093
  Height (cm)                                                                      
  Average                        159.63       167.93                 159.82        162.99
  SD                             8.63         5.50                   8.08          9.31
  N                              52           21                     22            94
  Wilcoxon signed‐rank test      Ref          *P* \< .001            *P* = .717    *P* = .027
                                 ---          Ref                    *P* = .002    *P* = .015
                                 ---          ---                    Ref           *P* = .156
  Body weight (kg)                                                                 
  Average                        54.18        59.11                  57.90         61.61
  SD                             12.26        10.18                  9.59          11.49
  N                              51           21                     22            95
  Wilcoxon signed‐rank test      Ref          0.132                  *P* = .146    *P* \< .001
                                 ---          Ref                    *P* = .884    *P* = .287
                                 ---          ---                    Ref           *P* = .203
  BW loss \>5 kg over 6 months                                                     
  No (N)                         29           16                     12            75
  Yes (N)                        10           1                      0             1
  Fisher\'s exact test           Ref          *P* = .144             *P* = .092    *P* \< .001
                                 ---          Ref                    *P* = 1.000   *P* = .334
                                 ---          ---                    Ref           *P* = 1.000
  Body mass index                                                                  
  Average                        21.04        20.94                  22.55         23.09
  SD                             3.34         3.45                   2.72          3.27
  N                              51           21                     22            93
  Wilcoxon signed‐rank test      Ref          *P* = .536             *P* = .100    *P* = .002
                                 ---          Ref                    *P* = .037    *P* = .004
                                 ---          ---                    Ref           *P* = 0.477
  Smoking                                                                          
  Nonsmoker                      31 (58.5%)   6 (27.3%)              9 (39.1%)     63 (61.8%)
  Past smoker                    13 (24.5%)   5 (22.7%)              8 (34.8%)     22 (21.6%)
  Current smoker                 6 (11.3%)    8 (36.4%)              2 (8.7%)      12 (11.8%)
  Fisher\'s exact test           Ref          *P* = .020             *P* = .419    *P* = .933
                                 ---          Ref                    *P* = .119    *P* = .005
                                 ---          ---                    Ref           *P* = .226
  Alcohol drinking                                                                 
  Nondrinker                     33 (62.3%)   6 (27.3%)              6 (26.1%)     42 (41.2%)
  Past drinker                   3 (5.7%)     4 (18.2%)              0 (0.0%)      4 (3.9%)
  Current drinker                17 (32.1%)   9 (40.9%)              13 (56.5%)    49 (48.0%)
  Fisher\'s exact test           Ref          *P* = .032             *P* = .027    *P* = .055
                                 ---          Ref                    *P* = .144    *P* = .051
                                 ---          ---                    Ref           *P* = .398
  Familial history of PDAC                                                         
  No                             24 (45.3%)   14 (63.6%)             14 (60.9%)    67 (65.7%)
  Yes                            3 (5.7%)     0 (0.0%)               1 (4.3%)      3 (2.9%)
  Unknown                        26 (49.1%)   8 (36.4%)              8 (34.8%)     32 (31.4%)
  Fisher\'s exact test           Ref          *P* = .539             *P* = 1.000   *P* = .344
                                 ---          Ref                    *P* = 1.000   *P* = 1.000
                                 ---          ---                    Ref           *P* = .547

---, not applicable; BW, body weight; IPMN, intraductal papillary mucinous neoplasm; Ref, reference.

John Wiley & Sons, Ltd

3.3. Performance of blood mRNA screening system {#cas13971-sec-0011}
-----------------------------------------------

The sensitivity and specificity of the blood mRNA PDAC screening system for 53 PDAC patients and 102 noncancer subjects was 73.6% (95% CI, 59.7%‐84.7%) and 64.7% (54.6%‐73.9%), respectively. The specificity for chronic pancreatitis and IPMN patients was 63.6% (95% CI, 40.7%‐82.8%) and 47.8% (95% CI, 26.8%‐69.4%), respectively (Table [3](#cas13971-tbl-0003){ref-type="table"}). The sensitivity for the conventional tumor markers CEA and CA19‐9 was 41.5% (95% CI, 28.1%‐55.9%) and 71.7% (95% CI, 57.7%‐83.2%), respectively (Tables [4](#cas13971-tbl-0004){ref-type="table"} and [5](#cas13971-tbl-0005){ref-type="table"}). In noncancer subjects, the specificity for CEA and CA19‐9 was 96.1% (95% CI, 90.3%‐98.9%) and 97.1% (95% CI, 91.6%‐99.4%), respectively (Tables [4](#cas13971-tbl-0004){ref-type="table"} and [5](#cas13971-tbl-0005){ref-type="table"}). The PPVs of the mRNA blood screening system, CEA, and CA19‐9 for chronic pancreatitis and IPMN were 76.5%‐83.0%, 71.9%, and 95.1%, respectively (Tables [3](#cas13971-tbl-0003){ref-type="table"}, [4](#cas13971-tbl-0004){ref-type="table"}, [5](#cas13971-tbl-0005){ref-type="table"}); the respective values for noncancer subjects were 50.6%, 82.1%, and 92.9%, respectively. The NPVs of the mRNA blood screening system, CEA, and CA19‐9 for all cases were 86.1%, 81.1%, and 90.4%, respectively (Tables [3](#cas13971-tbl-0003){ref-type="table"}, [4](#cas13971-tbl-0004){ref-type="table"}, [5](#cas13971-tbl-0005){ref-type="table"}). Pearson\'s correlation analysis was applied between these conventional tumor markers and scores of the mRNA screening system. The correlation coefficients for CEA and CA19‐9 with scores of the mRNA screening system were 0.072 and 0.14, respectively, with *P*‐values of .308 and .048, respectively. These results indicate no correlation between CEA and the mRNA screening system, and very weak correlation between CA19‐9 and the mRNA screening system (Figure [2](#cas13971-fig-0002){ref-type="fig"}).

###### 

Senstivity and specificity of blood mRNA screening system for pancreatic ductal adenocarcinoma (PDAC)

                       PDAC          Chronic pancreatitis   IPMN          Noncancer
  -------------------- ------------- ---------------------- ------------- -------------
  Objective number     53            22                     23            102
  mRNA system result                                                      
  Positive             39 (73.6%)    8 (36.4%)              12 (52.2%)    36 (35.3%)
  Negative             14 (26.4%)    14 (63.6%)             11 (47.8%)    66 (64.7%)
  Sensitivity                                                             
  Point estimation     73.6%         0 (0.0%)               0 (0.0%)      0 (0.0%)
  95% CI               59.7%‐84.7%   ---                    ---           ---
  Specificity                                                             
  Point estimation     ---           63.6%                  47.8%         64.7%
  95% CI               ---           40.7%‐82.8%            26.8%‐69.4%   54.6%‐73.9%

---, not applicable; CI, confidence interval; IPMN, intraductal papillary mucinous neoplasm.
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###### 

Senstivity and specificity of carcinoembryonic antigen (CEA) for pancreatic ductal adenocarcinoma (PDAC)

                     PDAC          Chronic pancreatitis   IPMN          Noncancer
  ------------------ ------------- ---------------------- ------------- -------------
  Objective number   53            22                     23            102
  Result                                                                
  Positive           22 (41.5%)    9 (40.9%)              2 (8.7%)      4 (3.9%)
  Negative           31 (58.5%)    13 (59.1%)             21 (91.3%)    98 (96.1%)
  Sensitivity                                                           
  Point estimation   41.5%         ---                    ---           ---
  95% CI             28.1%‐55.9%   ---                    ---           ---
  Specificity                                                           
  Point estimation   ---           59.1%                  91.3%         96.1%
  95% CI             ---           36.4%‐79.3%            72.0%‐98.9%   90.3%‐98.9%

---, not applicable; CI, confidence interval; IPMN, intraductal papillary mucinous neoplasm.

John Wiley & Sons, Ltd

###### 

Senstivity and specificity of cancer antigen (CA)19‐9 for pancreatic ductal adenocarcinoma (PDAC)

                     PDAC          Chronic pancreatitis   IPMN          Noncancer
  ------------------ ------------- ---------------------- ------------- -------------
  Objective number   53            22                     23            102
  Result                                                                
  Positive           38 (71.7%)    2 (9.1%)               2 (8.7%)      3 (2.9%)
  Negative           15 (28.3%)    20 (90.9%)             21 (91.3%)    99 (97.1%)
  Sensitivity                                                           
  Point estimation   71.7%         ---                    ---           ---
  95% CI             57.7%‐83.2%   ---                    ---           ---
  Specificity                                                           
  Point estimation   ---           90.9%                  91.3%         97.1%
  95% CI             ---           70.8%‐98.9%            72.0%‐98.9%   91.6%‐99.4%

---, not applicable; CI, confidence interval; IPMN, intraductal papillary mucinous neoplasm.

John Wiley & Sons, Ltd

![Scatter plots of carcinoembryonic antigen (CEA), cancer antigen (CA)19‐9, and sum‐values of blood mRNA screening system for pancreatic ductular adenocarcinoma. Serum concentration values of CEA (A) and serum unit values of CA19‐9 (B) with sum‐values of the blood mRNA screening system of 53 patients with pancreatic ductular adenocarcinoma (filled circle), 23 with intraductal papillary mucinous neoplasm (open triangle), 22 with chronic pancreatitis (open diamond), and 102 noncancer subjects (open square). The interval of *y*‐axis and *x*‐axis values is expressed in logarithmic scale. Solid line indicates regression lines, dashed line indicates the cut‐off value for tumor markers (A, B). *R* ^2^ values are 0.021 (A) and 0.08 (B)](CAS-110-1364-g002){#cas13971-fig-0002}

Regarding disease stages, the blood mRNA screening system showed a sensitivity of 78.6% for stages I and II, and a similar value of 71.8% for stages III and IV (Table [6](#cas13971-tbl-0006){ref-type="table"}).

###### 

Sensitivity of mRNA screening system for pancreatic ductal adenocarcinoma (PDAC) staging

                                      Stage   
  ----------------------------------- ------- ------
  Number                              14      39
  Positive by mRNA screening system   11      28
  Sensitivity (%)                     78.6    71.8

John Wiley & Sons, Ltd

3.4. Clinical characteristics and blood mRNA screening system {#cas13971-sec-0012}
-------------------------------------------------------------

In terms of clinical parameters and sum‐values of the blood mRNA screening system, we applied correlation analyses for continuous data (age, height, and body weight) and *t* tests for category data (gender, body weight loss of more than 5 kg over 6 months, smoking, alcohol drinking, and familial history of PDAC) with sum‐values of the blood mRNA screening system (Table [S4](#cas13971-sup-0006){ref-type="supplementary-material"}). Although the *P* value for the age correlation analysis was less than .05, correlation efficiency was weak (0.145). Average values of the sum‐values of the blood mRNA screening system for nonsmoker and current smoker were significantly different (*P* = .047), but both values were less than zero. Although the sum‐value of past drinker was significantly higher than those of nondrinker and current drinker (*P* = .045 and *P* = .043, respectively), the sum‐value for the current drinker was not higher than current drinker or nondrinker.

4. DISCUSSION {#cas13971-sec-0013}
=============

In this study, we developed a blood mRNA PDAC screening system measuring the expression of 56 genes in whole blood by RTD‐PCR, followed by weighted linear summation. We undertook a multicenter clinical study to validate the performance of this blood mRNA screening system for PDAC detection, by gene expression analysis using RTD‐PCR. This system showed that sensitivity was 73.6% and the specificity for healthy subjects was 64.7%.

The principle of this system is unique, being based on changes in gene expression in the peripheral blood.[6](#cas13971-bib-0006){ref-type="ref"}, [7](#cas13971-bib-0007){ref-type="ref"}, [10](#cas13971-bib-0010){ref-type="ref"}, [11](#cas13971-bib-0011){ref-type="ref"} Previously, we reported that PDAC is related to inflammatory changes in local tumor tissue, as well in peripheral blood.[7](#cas13971-bib-0007){ref-type="ref"}, [10](#cas13971-bib-0010){ref-type="ref"} Therefore, we assumed that alterations in the gene expression profile in the peripheral blood of PDAC patients would be associated with systemic inflammatory responses of the host. Based on this principle, we selected genes that showed differences in expression between the whole blood from PDAC patients and noncancer subjects.

The prognosis of PDAC is extremely poor due to in part to difficulty of diagnosis in the early stages.[12](#cas13971-bib-0012){ref-type="ref"} At present, there is no definitive screening method for PDAC, and various methods are used clinically, including ultrasonography and computed tomography, for imaging‐based diagnosis and determination of tumor markers in blood.[13](#cas13971-bib-0013){ref-type="ref"} With regard to blood test tumor markers, CA19‐9,[14](#cas13971-bib-0014){ref-type="ref"} Span‐1,[15](#cas13971-bib-0015){ref-type="ref"} CA50, CA242, DUPAN‐2, and TAG‐72[16](#cas13971-bib-0016){ref-type="ref"}, [17](#cas13971-bib-0017){ref-type="ref"}, [18](#cas13971-bib-0018){ref-type="ref"} are categorized as glucose‐chain antigens; CEA is an embryonic antigen[19](#cas13971-bib-0019){ref-type="ref"} that is typically present in high levels in PDAC, although not in all cases. In addition to these conventional tumor markers, a new approach has been developed using excreted small particles, called exosomes; these are believed to include molecules specific for cancers,[20](#cas13971-bib-0020){ref-type="ref"} although the analysis methods are still under development.

As diagnosis of PDAC in the early stages is extremely rare, there are insufficient data regarding the performance of the mRNA screening system for early‐stage PDAC. The PDAC patients in this study were mainly in advanced stages (ie, III or IV); only 14 patients were in stage I or II. The sensitivity of the mRNA screening system for these PDAC patients was 78.6%, illustrating the potential benefit of this system for early detection of PDAC. We previously disclosed that PDAC local tissues were associated with inflammation, even if they were still small.[7](#cas13971-bib-0007){ref-type="ref"} Thus, the high sensitivity of the mRNA screening system, capable of detecting PDAC in early stages, might be an important beneficial feature, one that has proven difficult using other conventional tumor marker systems. Based on this previous study, the principle of the mRNA screening system relies on gene expression alteration of peripheral blood cells affected by development of PDAC. This is the feature that distinguishes the system from conventional tumor markers (ie, CEA and CA19‐9), which are produced by cancer tissues. In this context, the novel mRNA system would be a useful screening method as the examination involves a blood test, which can be undertaken without the need for specific medical devices and is minimally invasive.

The establishment of a PDAC screening algorithm requires further development, including the novel blood mRNA screening system described herein, along with other tumor markers and diagnostic imaging tools.[21](#cas13971-bib-0021){ref-type="ref"} Although ultrasonography is noninvasive, it cannot be used to determine dilatation of the pancreatic duct or tumorous lesions in the pancreas; therefore, patients also require endoscopy,[22](#cas13971-bib-0022){ref-type="ref"} computed tomography, and MRI examinations.[23](#cas13971-bib-0023){ref-type="ref"} As discussed above, conventional tumor markers are not sufficient for screening for PDAC in the early stages, which could allow the disease to be cured by surgery.

The genes included in this system were selected biostatistically, based on changes in their expression levels in the whole blood of PDAC patients forming a different cohort from that of the clinical study. The mechanisms by which these genes are affected in PDAC are intriguing; some genes are involved in immunological processes, consistent with the previous finding that PDAC is associated with both local and systemic immune reactions.[7](#cas13971-bib-0007){ref-type="ref"} Further investigations to determine the biological significance of these genes will provide insight into the immunopathological features of PDAC, leading to further development of diagnostic tools as well as immunological treatments for the disease.

In conclusion, we developed a novel in vitro diagnostic system based on assessment of the host immune response to PDAC. As it remains unclear how this novel system should best be used as an adjunct to conventional PDAC diagnostic or screening systems, further investigations to improve the PDAC screening algorithm, including our novel screening system, should be undertaken to improve the prognosis of PDAC patients by diagnosis in the early stages of disease progression.
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